Advertisement

AAPS PharmSciTech

, 20:105 | Cite as

Application of the SeDeM Expert System in Studies for Direct Compression Suitability on Mixture of Rhodiola Extract and an Excipient

  • Shulin Wan
  • Rui Yang
  • Han Zhang
  • Xuelian Li
  • Mingxian Gu
  • Tianbing Guan
  • Jianbing Ren
  • Huimin SunEmail author
  • Chuanyun DaiEmail author
Research Article

Abstract

The SeDeM expert system is used to reveal direct compression (DC) suitability of the active ingredients and excipients in preformulation. In this study, the system was used to predict compressibility of rhodiola extract (RhE) and its mixture with excipients. The parameter index (IP), parameter profile index (IPP), and good compressibility index (IGC) of RhE mixtures with different fillers were investigated. The results showed that RhE and mixture with lactose or starch were not suitable for DC according to the values of IP, IPP, and IGC, which can be corrected by pregelatinized starch (P-STA). The quality of tablets corrected by P-STA all satisfied the USP monograph limit. The findings from this study showed that the system is a useful tool to predict DC suitability on the mixture of RhE and an excipient.

KEY WORDS

SeDeM expert system preformulation direct compression rhodiola extract 

Notes

Acknowledgements

We wish to thank Anhui Shanhe Medicinal Excipients Co., Ltd., China, and Meggle Pharma-Excipients & Technology Co., Ltd., Germany, for providing the necessary materials to carry out this study. This work has emanated from research conducted with the financial support of the National Science & Technology Major Project Key New Drug Creation and Manufacturing Program (2015ZX09303001002007), the Industrial Key Research and Development Project of the Chongqing Science & Technology Commission (cstc2017zdcy-cdyf193), and the Postgraduate Science and Technology Innovation Program of Chongqing University of Science and Technology (YKJCX1820507).

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

Disclaimer

The authors alone are responsible for the content and writing of this article.

References

  1. 1.
    Suñé Negre JM, Roig Carreras M, Fuster García R, Hernández Pérez C, Ruhí Roura R, García Montoya E, et al. Nueva metodología de preformulación galénica para la caracterización de ustancias en relación a su viabilidad para la compresión: diagrama SeDeM. Cien Technol Pharm. 2005;15(3):125–36.Google Scholar
  2. 2.
    Borges PF, Pérez-Lozano P, Suñé-Negre JM, Miñarro M, Manich A, Jo E, et al. The role of SeDeM for characterizing the active substance and polyvinyilpyrrolidone eliminating metastable forms in an oral lyophilizate—a preformulation study. PLoS One. 2018;13(4):e0196049.  https://doi.org/10.1371/journal.pone.0196049.CrossRefGoogle Scholar
  3. 3.
    Aguilar-Díaz JE, García-Montoya E, Suñe-Negre JM, Pérez-Lozano P, Miñarro M, Ticó JR. Predicting orally disintegrating tablets formulations of ibuprophen tablets: an application of the new SeDeM-ODT expert system. Eur J Pharm Biopharm. 2012;80(3):638–48.CrossRefGoogle Scholar
  4. 4.
    Hamman H, Hamman J, Wessels A, Scholtz J, Steenekamp JH. Development of multiple-unit pellet system tablets by employing the SeDeM expert diagram system I: pellets with different sizes. Pharm Dev Technol. 2017;23(7):706–14.CrossRefGoogle Scholar
  5. 5.
    Tadwee I, Shahi S. Formulation development of losartan potassium immediate release tablets and process optimization using SeDeM expert system. J Appl Pharm Sci. 2018;8(2):33–43.Google Scholar
  6. 6.
    Hu X, Lin S, Yu D, Qiu S, Zhang X, Mei R. A preliminary study: the anti-proliferation effect of salidroside on different human cancer cell lines. Cell Biol Toxicol. 2010;26(6):499–507.CrossRefGoogle Scholar
  7. 7.
    Ishaque S, Shamseer L, Bukutu C, Vohra S. Rhodiola rosea for physical and mental fatigue: a systematic review. BMC Complement Altern Med. 2012;12(1):1–9.CrossRefGoogle Scholar
  8. 8.
    Guo ZY, Gao LP, Li WW. Protective effect of Rhodiola extract against cisplatin-induced damage to TM4 sertoli cells in mice. Natl J Androl. 2013;19(11):1027–33.Google Scholar
  9. 9.
    Mao JJ, Xie SX, Zee J, Soeller I, Li QS, Rockwell K, et al. Rhodiola rosea versus sertraline for major depressive disorder: a randomized placebo-controlled trial. Phytomed Int J Phytother Phytopharmacol. 2015;22(3):394–9.Google Scholar
  10. 10.
    Zou H, Liu X, Han T, Hu D, Wang Y, Yuan Y, et al. Salidroside protects against cadmium-induced hepatotoxicity in rats via GJIC and MAPK pathways. PLoS One. 2014;10(6):e0129788.  https://doi.org/10.1371/journal.pone.0129788.CrossRefGoogle Scholar
  11. 11.
    Wu YL, Piao DM, Han XH, Nan JX. Protective effects of salidroside against acetaminophen-induced toxicity in mice. Biol Pharm Bull. 2008;31(8):1523–9.CrossRefGoogle Scholar
  12. 12.
    Zhu Y, Shi YP, Wu D, Ji YJ, Wang X, Chen HL, et al. Salidroside protects against hydrogen peroxide-induced injury in cardiac H9c2 cells via PI3K-Akt dependent pathway. DNA Cell Biol. 2011;30(10):809–19.CrossRefGoogle Scholar
  13. 13.
    Tan CB, Mei G, Xu WR, Yang XY, Zhu XM, Du GH. Protective effects of salidroside on endothelial cell apoptosis induced by cobalt chloride. Biol Pharm Bull. 2009;32(8):1359–63.CrossRefGoogle Scholar
  14. 14.
    Fang DL, Chen Y, Xu B, Ren K, He ZY, He LL, et al. Development of lipid-shell and polymer core nanoparticles with water-soluble salidroside for anti-cancer therapy. Int J Mol Sci. 2014;15(3):3373–88.CrossRefGoogle Scholar
  15. 15.
    Gavrilov AS, Shchegolev AA, Larionov LP. New prophylactic preparations of Rhodiola rosea. Pharm Chem J. 2003;37(12):641–4.CrossRefGoogle Scholar
  16. 16.
    Yue GC, Chen LH, Guan YM, Zhang MM, Tang S. Micromeritics evaluation of new direct compression excipients. China Pharm. 2014;25(9):833–6.Google Scholar
  17. 17.
    European Pharmacopoeia, 8th edn. Strasbourg: Council of Europe; 2014.Google Scholar
  18. 18.
    Bhavsar PH, Bhatt B, Oza C, Trivedi S, Shah S. A review on: SeDeM expert system in formulation development of pharmaceutical forms. J Pharm Sci Bioscientific Res. 2015;5(4):363–9.Google Scholar
  19. 19.
    Pérez P, Suñé-Negre JM, Miñarro M, Roig M, Fuster R, García-Montoya E, et al. A new expert systems (SeDeM diagram) for control batch powder formulation and preformulation drug products. Eur J Pharm Biopharm. 2006;64(3):351–9.CrossRefGoogle Scholar
  20. 20.
    Aguilardíaz JE, Garcíamontoya E, Pérezlozano P, Suñenegre JM, Miñarro M, Ticó JR. The use of the SeDeM diagram expert system to determine the suitability of diluents–disintegrants for direct compression and their use in formulation of ODT. Eur J Pharm Biopharm. 2009;73(3):414–23.CrossRefGoogle Scholar
  21. 21.
    Raymond CR, Paul JS, Marian EQ. Handbook of pharmaceutical excipients. 6th ed. London: the Pharmaceutical Press; 2009.Google Scholar
  22. 22.
    European Pharmacopeia, 8th edn. Strasbourg: Dosage forms monographs; 2013.Google Scholar
  23. 23.
    Suñé-Negre JM, Roig M, Fuster R, Hernández C, Ruhí R, García-Montoya E, et al. New classification of directly compressible (DC) excipients in function of the SeDeM diagarm expert system. Int J Pharm. 2014;470(1–2):15–27.CrossRefGoogle Scholar
  24. 24.
    Pharmacopoeia of the People’s Republic of China. Beijing: China Medical Science and Technology Press; 2015.Google Scholar
  25. 25.
    USP 32/NF 27, The United States Pharmacopeia, 32ª Rev. and The National Formulary, 27th edn. In: USP Monographs: 1217: Tablet Breaking Force, editor. Rockville: United States Pharmacopeial Convention, Inc; 2009.Google Scholar
  26. 26.
    European Pharmacopeia, 7th edn. Strasbourg: Council of Europe; 2011.Google Scholar
  27. 27.
    USP 32/NF 27, The United States Pharmacopeia, 32ª rev and The National Formulary, 27th edn. In: USP Monographs: 1216: Tablet Friability, editor. Rockville: United States Pharmacopoeial Convention, Inc; 2009.Google Scholar
  28. 28.
    United States Pharmacopeia, 32nd Revision. Rockville: Convention, Inc; 2009.Google Scholar
  29. 29.
    Gregory Thoorens FK, Leclercq B, Carlin B, Evrard B. Microcrystalline cellulose, a direct compression binder in a quality by design environment-a review. Int J Pharm. 2014;473:64–72.CrossRefGoogle Scholar
  30. 30.
    Rojas J, Ciro Y, Correa L. Functionality of chitin as a direct compression excipient: an acetaminophen comparative study. Carbohydr Polym. 2014;103(1):134–9.CrossRefGoogle Scholar
  31. 31.
    Kato Y, Ohkuma M, Shimada Y, Sunada H. Evaluation of the flowability of surface-modified preparations by the measurement of the inter-particle adhesive force. J Drug Deliv Sci Technol. 2005;15(3):217–21.CrossRefGoogle Scholar
  32. 32.
    Ileleji KE, Zhou B. The angle of repose of bulk corn stover particles. Powder Technol. 2008;187(2):110–8.CrossRefGoogle Scholar
  33. 33.
    Yan D, Zhao LJ, Yi F, Xu DS. Compression characterization of the mixture of direct compression excipients and traditional Chinese medicine (TCM) extract powders. Med Plant. 2013;4(5):9–14.Google Scholar
  34. 34.
    Singh I, Kumar P. Preformulation studies for direct compression suitability of cefuroxime axetil and paracetamol: a graphical representation using SeDeM diagram. Acta Pol Pharm. 2012;69(1):87.PubMedGoogle Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2019

Authors and Affiliations

  1. 1.Chongqing University of Science and TechnologyChongqingChina
  2. 2.National Institutes for Food and Drug ControlBeijingChina
  3. 3.Chongqing LIYUN Nozzle Co., Ltd.ChongqingChina

Personalised recommendations